bendamustine hydrochloride has been researched along with Dermatitis Medicamentosa in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiba, K; Hashida, T; Hirano, T; Hosohata, K; Ikesue, H; Ishikawa, T; Maegawa, N; Miyasaka, M; Mori, Y; Muroi, N; Nakamura, T; Shimomura, Y; Takano, A; Uchida, M; Yamaguchi, Y | 1 |
| Kempf, W; Mitteldorf, C; Tronnier, M; Wollert, E | 1 |
| Berardi Vilei, S; Berthod, G; Caspar, C; Eckhardt, K; Fischer, N; Hitz, F; Mey, U; Pabst, T; Zucca, E | 1 |
| Izutsu, K; Maruyama, D; Nisikori, M; Ohmachi, K; Suzuki, T | 1 |
| Abe, H; Asano, H; Fukayama, M; Higo, T; Kurokawa, M; Miyagaki, T; Nakamura, F; Senda, N; Shinohara, A; Yoshizaki, A | 1 |
| Haga, H; Hishizawa, M; Kadowaki, N; Kawabata, H; Kitano, T; Kitawaki, T; Kobayashi, M; Kondo, T; Nishikori, M; Takaori-Kondo, A; Takei, Y; Yamashita, K | 1 |
| Hatake, K; Kusano, Y; Terui, Y; Yokoyama, M | 1 |
| Alamdari, HS; Cassarino, DS; Chiu, MW; Pinter-Brown, L | 1 |
| Gavini, A; Olszewski, AJ; Telang, GH | 1 |
| Eide, MJ; Mahmoud, BH | 1 |
1 review(s) available for bendamustine hydrochloride and Dermatitis Medicamentosa
| Article | Year |
|---|---|
[Recommendation for the optimal use of bendamustine in Japan].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Drug Eruptions; Evidence-Based Medicine; Hepatitis B; Humans; Immunocompromised Host; Japan; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Nausea; Nitrogen Mustard Compounds; Opportunistic Infections; Rituximab; Vasculitis | 2014 |
1 trial(s) available for bendamustine hydrochloride and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Comorbidity; Dose-Response Relationship, Drug; Drug Eruptions; Fatigue; Female; Heart Diseases; Hematologic Diseases; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Nitrogen Mustard Compounds; Rituximab; Salvage Therapy; Thalidomide; Treatment Outcome | 2013 |
8 other study(ies) available for bendamustine hydrochloride and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Drug Resistance, Neoplasm; Female; Humans; Incidence; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Assessment; Risk Factors; Rituximab | 2020 |
Generalized maculopapular and vesicular rash.
Topics: Acyclovir; Aged; Bendamustine Hydrochloride; Drug Eruptions; Epidermis; Herpes Zoster; Humans; Immunoblastic Lymphadenopathy; Keratinocytes; Lymphocytes; Lymphoma, T-Cell; Male; Programmed Cell Death 1 Receptor; Skin | 2018 |
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Eruptions; Female; Humans; Lymphoma, Follicular; Nitrogen Mustard Compounds; Paraneoplastic Syndromes; Pemphigus; Recurrence; Rituximab; Salvage Therapy | 2015 |
Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine.
Topics: Adult; Aged; Bendamustine Hydrochloride; Biomarkers; CD8-Positive T-Lymphocytes; Drug Eruptions; Eosinophils; Female; Humans; Leukocyte Count; Lymphoma, B-Cell; Male; Middle Aged; Skin Diseases; Treatment Outcome | 2015 |
Lichenoid drug eruption associated with Bendamustine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Eruptions; Humans; Lichenoid Eruptions; Lymphoma, Follicular; Male; Recurrence; Rituximab; Salvage Therapy | 2016 |
Severe cutaneous interface drug eruption associated with bendamustine.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Drug Eruptions; Humans; Lymphoma, B-Cell; Male; Nitrogen Mustard Compounds; Prednisone; Vincristine | 2010 |
Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biopsy; Drug Eruptions; Exanthema; Female; Humans; Leukemia, Prolymphocytic, B-Cell; Nitrogen Mustard Compounds; Purpura; Skin; Treatment Outcome | 2012 |
Bendamustine-induced "flagellate dermatitis".
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds | 2012 |